Search

everythinglearnresearchcommunity

for

Search:↓

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Only anti-androgenic drugs likely halt AGA progression.

Androgenetic alopecia is the most common type of non-scarring hair loss, especially in young males, and early diagnosis and treatment are important.

Videodermoscopy is effective for diagnosing different types of non-scarring hair loss.

ViviScal®, a food supplement, was found to be highly effective in treating hereditary hair loss in young males, while fish extract showed no impact.

Herbal preparation effectively promotes hair growth and reduces hair loss.

The 1565 nm non-ablative fractional laser is more effective and satisfying than 5% minoxidil for treating hair loss.

Hair loss, prostate size, and urinary issues are related due to androgen effects.

Reflectance confocal microscopy can help tell apart scarring from non-scarring hair loss.

Hair loss in androgenic alopecia may be linked to increased local androgen activities, but not to estrogen levels.

The study suggests computer-assisted analysis of scalp biopsies could improve hair loss diagnosis but needs more validation.

Accurate diagnosis is crucial to distinguish alopecia areata incognita from androgenetic alopecia in men for proper treatment.

Autologous follicular stem cells improved hair loss in 57% of patients.

Androgenetic alopecia in men aged 46 is not significantly linked to depression, anxiety, quality of life, self-esteem, or sexual symptoms.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Women with certain types of hair loss may have low iron levels, and iron supplements could help.

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

Platelet-rich plasma, microneedling with minoxidil, and topical finasteride are promising treatments for hair loss.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Non-prescription products can help manage androgenic alopecia.

Deep learning can improve non-invasive alopecia diagnosis using hair images.

Certain gene variations and irregular X chromosome activity may contribute to hair loss in women who can have children.

Androgenetic alopecia with telogen effluvium is the most common hair loss in women with hirsutism.

15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.

Genetic risk for hair loss can increase depression risk, but depression doesn't increase hair loss risk.

The new gel for hair loss is safe, effective, and reduces side effects.